Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure–activity relationship and biological activity as potential antitumor and anticonvulsant agents
2021 ◽
Vol 214
◽
pp. 113222
2010 ◽
Vol 45
(12)
◽
pp. 5887-5898
◽
2013 ◽
Vol 64
◽
pp. 579-588
◽
2018 ◽
Vol 71
(8)
◽
pp. 702-712
◽
2018 ◽
Vol 157
◽
pp. 665-682
◽
2018 ◽
Vol 25
(30)
◽
pp. 3560-3576
◽
2016 ◽
Vol 12
(4)
◽
pp. 338-346
◽